154 related articles for article (PubMed ID: 37130471)
1. Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold.
Albadari N; Xie Y; Liu T; Wang R; Gu L; Zhou M; Wu Z; Li W
Eur J Med Chem; 2023 Jul; 255():115423. PubMed ID: 37130471
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of MDM2 inhibitor MI-219 against lung cancer cells alone or in combination with MDM2 knockdown, a XIAP inhibitor or etoposide.
Zheng M; Yang J; Xu X; Sebolt JT; Wang S; Sun Y
Anticancer Res; 2010 Sep; 30(9):3321-31. PubMed ID: 20944104
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous activation of p53 and inhibition of XIAP enhance the activation of apoptosis signaling pathways in AML.
Carter BZ; Mak DH; Schober WD; Koller E; Pinilla C; Vassilev LT; Reed JC; Andreeff M
Blood; 2010 Jan; 115(2):306-14. PubMed ID: 19897582
[TBL] [Abstract][Full Text] [Related]
4. MDM2 as a target for ellagic acid‑mediated suppression of prostate cancer cells in vitro.
Mohammed Saleem YI; Selim MI
Oncol Rep; 2020 Sep; 44(3):1255-1265. PubMed ID: 32705219
[TBL] [Abstract][Full Text] [Related]
5. Discovery of
Wu Z; Gu L; Zhang S; Liu T; Lukka PB; Meibohm B; Bollinger JC; Zhou M; Li W
J Med Chem; 2021 Feb; 64(4):1930-1950. PubMed ID: 33556244
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Dual Inhibitors of MDM2 and XIAP for Cancer Treatment.
Gu L; Zhang H; Liu T; Zhou S; Du Y; Xiong J; Yi S; Qu CK; Fu H; Zhou M
Cancer Cell; 2016 Oct; 30(4):623-636. PubMed ID: 27666947
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of MDM2 by nilotinib contributes to cytotoxicity in both Philadelphia-positive and negative acute lymphoblastic leukemia.
Zhang H; Gu L; Liu T; Chiang KY; Zhou M
PLoS One; 2014; 9(6):e100960. PubMed ID: 24968304
[TBL] [Abstract][Full Text] [Related]
8. L-Tetrahydropalmatine Induces Apoptosis in EU-4 Leukemia Cells by Down-Regulating X-Linked Inhibitor of Apoptosis Protein and Increases the Sensitivity Towards Doxorubicin.
Li S; Chen D; Pei R; Lu Y; Zhang P; Ma J; Liu X; Du X; Sha K; Chen L; Cao J; Zhuang X; Wu J; Lin L; Fan Z; Ye P; Tang S; Zhang B; Shi X; Li K
Curr Mol Med; 2017; 17(3):236-245. PubMed ID: 28721806
[TBL] [Abstract][Full Text] [Related]
9. Berberine induces apoptosis in p53-null leukemia cells by down-regulating XIAP at the post-transcriptional level.
Liu J; Zhang X; Liu A; Liu S; Zhang L; Wu B; Hu Q
Cell Physiol Biochem; 2013; 32(5):1213-24. PubMed ID: 24335171
[TBL] [Abstract][Full Text] [Related]
10. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.
Feng FY; Zhang Y; Kothari V; Evans JR; Jackson WC; Chen W; Johnson SB; Luczak C; Wang S; Hamstra DA
Neoplasia; 2016 Apr; 18(4):213-22. PubMed ID: 27108384
[TBL] [Abstract][Full Text] [Related]
11. XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling.
Huang X; Wu Z; Mei Y; Wu M
EMBO J; 2013 Aug; 32(16):2204-16. PubMed ID: 23749209
[TBL] [Abstract][Full Text] [Related]
12. Regulation of XIAP translation and induction by MDM2 following irradiation.
Gu L; Zhu N; Zhang H; Durden DL; Feng Y; Zhou M
Cancer Cell; 2009 May; 15(5):363-75. PubMed ID: 19411066
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival.
Liu T; Zhang H; Xiong J; Yi S; Gu L; Zhou M
Mol Cancer; 2015 Mar; 14():65. PubMed ID: 25888903
[TBL] [Abstract][Full Text] [Related]
14. Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5.
Carter BZ; Mak DH; Schober WD; Dietrich MF; Pinilla C; Vassilev LT; Reed JC; Andreeff M
Blood; 2008 Apr; 111(7):3742-50. PubMed ID: 18187663
[TBL] [Abstract][Full Text] [Related]
15. Structure-based discovery of novel α-aminoketone derivatives as dual p53-MDM2/MDMX inhibitors for the treatment of cancer.
Luo HJ; Si DJ; Sun XJ; Wang MY; Yang YB; Wang B; Wen HM; Li W; Liu J
Eur J Med Chem; 2023 Apr; 252():115282. PubMed ID: 36989812
[TBL] [Abstract][Full Text] [Related]
16. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
[TBL] [Abstract][Full Text] [Related]
17. Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway.
Huang M; Zhang H; Liu T; Tian D; Gu L; Zhou M
Mol Cancer Ther; 2013 Feb; 12(2):184-94. PubMed ID: 23243057
[TBL] [Abstract][Full Text] [Related]
18. The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma.
Maser T; Zagorski J; Kelly S; Ostrander A; Goodyke A; Nagulapally A; Bond J; Park Y; Saulnier Sholler G
Cancer Med; 2020 Nov; 9(21):8144-8158. PubMed ID: 33034426
[TBL] [Abstract][Full Text] [Related]
19. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
Wang H; Yu D; Agrawal S; Zhang R
Prostate; 2003 Feb; 54(3):194-205. PubMed ID: 12518324
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia.
Huang Z; Zhou J; Jiang Y; Han Y; Wang X; Li F; Jiang S; Yu K; Zhang S
J Cell Mol Med; 2023 Jun; 27(12):1682-1696. PubMed ID: 37154878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
